BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22544734)

  • 1. Drug-induced cholestatic hepatitis: how late can it occur even after the cessation of the culpable drug?
    Zamani N; Mohammad Alizadeh A
    Neuro Oncol; 2012 Jul; 14(7):830. PubMed ID: 22544734
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe cholestatic hepatitis due to temozolomide: an adverse drug effect to keep in mind. Case report and review of literature.
    Grieco A; Tafuri MA; Biolato M; Diletto B; Di Napoli N; Balducci N; Vecchio FM; Miele L
    Medicine (Baltimore); 2015 Mar; 94(12):e476. PubMed ID: 25816026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system.
    Sarganas G; Orzechowski HD; Klimpel A; Thomae M; Kauffmann W; Herbst H; Bronder E; Garbe E
    Neuro Oncol; 2012 May; 14(5):541-6. PubMed ID: 22394496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproic acid related idiosyncratic drug induced hepatotoxicity in a glioblastoma patient treated with temozolomide.
    Neyns B; Hoorens A; Stupp R
    Acta Neurol Belg; 2008 Dec; 108(4):131-4. PubMed ID: 19239041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temozolomide induced liver injury.
    Dixit S; Hingorani M; Afzal P; Campbell AP
    Acta Neurol Belg; 2011 Sep; 111(3):249-51. PubMed ID: 22141295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temozolomide-induced biliary ductopenia: a case report.
    Balakrishnan A; Ledford R; Jaglal M
    J Med Case Rep; 2016 Feb; 10():33. PubMed ID: 26846183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute temozolomide induced liver injury: mixed type hepatocellular and cholestatic toxicity.
    Aygun C; Altınok AY; Çakır A; Agan AF; Balaban Y
    Acta Gastroenterol Belg; 2016; 79(2):363-365. PubMed ID: 27821033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temozolomide-induced liver damage. A case report.
    Becker F; Hecht M; Schmidtner J; Semrau S; Fietkau R
    Strahlenther Onkol; 2014 Apr; 190(4):408-10. PubMed ID: 24452817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute temozolomide induced liver injury : Mixed type hepatocellular and cholestatic toxicity.
    Aygun C; Altınok AY; Çakır A; Agan AF; Balaban Y
    Acta Gastroenterol Belg; 2016; 79(4):487-489. PubMed ID: 28209108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute non-oliguric kidney failure and cholestatic hepatitis induced by ibuprofen and acetaminophen: a case report.
    Zaffanello M; Brugnara M; Angeli S; Cuzzolin L
    Acta Paediatr; 2009 May; 98(5):903-5. PubMed ID: 19183124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temozolomide: fatal hepatic failure.
    Prescrire Int; 2014 Sep; 23(152):214. PubMed ID: 25325123
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment-related Acute Myeloid Leukaemia After Temozolomide for Glioblastoma Multiforme.
    Tan CW; See SJ; Tham CK; Ang AL
    Ann Acad Med Singap; 2014 Jun; 43(6):334-7. PubMed ID: 25028145
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and histological features of idiosyncratic acute liver injury caused by temozolomide.
    Grant LM; Kleiner DE; Conjeevaram HS; Vuppalanchi R; Lee WM
    Dig Dis Sci; 2013 May; 58(5):1415-21. PubMed ID: 23212393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temozolomide (Temodar).
    Wesolowski JR; Rajdev P; Mukherji SK
    AJNR Am J Neuroradiol; 2010 Sep; 31(8):1383-4. PubMed ID: 20538821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic encephalopathy after treatment with temozolomide.
    Goldbecker A; Tryc AB; Raab P; Worthmann H; Herrmann J; Weissenborn K
    J Neurooncol; 2011 May; 103(1):163-6. PubMed ID: 20730617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant viral and bacterial encephalitis after temozolomide for glioblastoma.
    Tsai JP; Petrescu N; Mason WP; Casaubon LK
    Can J Neurol Sci; 2014 Jan; 41(1):84-5. PubMed ID: 24384343
    [No Abstract]   [Full Text] [Related]  

  • 17. How lymphotoxic is dose-intensified temozolomide? The glioblastoma experience.
    Wick W; Weller M
    J Clin Oncol; 2005 Jun; 23(18):4235-6; author reply 4236. PubMed ID: 15961774
    [No Abstract]   [Full Text] [Related]  

  • 18. Vanishing bile duct syndrome in the context of concurrent temozolomide for glioblastoma.
    Mason M; Adeyi O; Fung S; Millar BA
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25432915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide.
    Villano JL; Collins CA; Manasanch EE; Ramaprasad C; van Besien K
    Lancet Oncol; 2006 May; 7(5):436-8. PubMed ID: 16648049
    [No Abstract]   [Full Text] [Related]  

  • 20. Paracetamol-induced cholestatic and granulomatous liver injuries.
    Lindgren A; Aldenborg F; Norkrans G; Olaison L; Olsson R
    J Intern Med; 1997 May; 241(5):435-9. PubMed ID: 9183313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.